✦ LIBER ✦

The treatment of glucocorticoid-induced osteoporosis

✍ Scribed by Dana Cohen; Jonathan D Adachi

Book ID: 116697283
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 152 KB
Volume: 88
Category: Article
ISSN: 0960-0760
DOI: 10.1016/j.jsbmb.2004.01.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Teriparatide in the treatment of glucoco

Teriparatide in the treatment of glucocorticoid-induced osteoporosis

✍ J.P. Bilezikian 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Superiority of alfacalcidol over plain v

Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis

✍ J.D. Ringe; A. Dorst; H. Faber; E. Schacht; V.W. Rahlfs 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 262 KB

Active comparator trial of teriparatide

Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis

✍ Taylor, Kathleen A.; Saag, Kenneth G.; Shane, Elizabeth; Boonen, Steven; Donley, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Efficacy of intravenous alendronate for

Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases

✍ Yuzaburo Inoue; Naoki Shimojo; Shuichi Suzuki; Takayasu Arima; Minako Tomiita; M 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 102 KB

Questions on the superiority of alfacalc

Questions on the superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis

✍ Johann D. Ringe 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 101 KB

Osteogenic growth peptide effects on pri

Osteogenic growth peptide effects on primary human osteoblast cultures: Potential relevance for the treatment of glucocorticoid-induced osteoporosis

✍ Adriano Spreafico; Bruno Frediani; Caterina Capperucci; Alessandra Leonini; Dari 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

## Abstract The osteogenic growth peptide (OGP) is a naturally occurring tetradecapeptide that has attracted considerable clinical interest as a bone anabolic agent and hematopoietic stimulator. In vivo studies on animals have demonstrated that the synthetic peptide OGP (10–14), reproducing the OGP